lenalidomide has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agarwal, N; Apolo, AB; Galsky, MD; Gimpel-Tetra, K; Godbold, JH; Lee, KM; Lowe, N; Oh, WK; Poole, A; Soto, R; Tsao, CK | 1 |
| Qian, W; Wang, B; Xu, G; Yang, M | 1 |
| Chinen, Y; Fushiki, S; Horiike, S; Kiyota, M; Kobayashi, T; Kuroda, J; Maegawa, S; Mizutani, S; Nagoshi, H; Sasaki, N; Shimura, Y; Tando, S; Taniwaki, M; Tatekawa, S; Tsukamoto, T | 1 |
1 trial(s) available for lenalidomide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Phase Ib/II trial of gemcitabine, cisplatin, and lenalidomide as first-line therapy in patients with metastatic urothelial carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Gemcitabine; Humans; Lenalidomide; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Thalidomide; Urothelium | 2014 |
2 other study(ies) available for lenalidomide and Carcinoma, Anaplastic
| Article | Year |
|---|---|
A rare case of nasopharyngeal carcinoma in a patient with multiple myeloma after treatment by lenalidomide.
Topics: Carcinoma; Humans; Immunologic Factors; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasms, Second Primary; Thalidomide | 2015 |
Quadruple Cancers of Non-producing Multiple Myeloma, Cholangiocellular Carcinoma, and Two Different Thyroid Cancers.
Topics: Aged; Bile Duct Neoplasms; Bortezomib; Carcinoma; Carcinoma, Neuroendocrine; Carcinoma, Papillary; Cholangiocarcinoma; Humans; Lenalidomide; Male; Multiple Myeloma; Thalidomide; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |